United States Anti-Neutrophil Cytoplasmic Antibody Market Report 2016

December 2016 | 99 pages | ID: UD1F201CFF1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti-Neutrophil Cytoplasmic Antibody

Revenue, means the sales value of Anti-Neutrophil Cytoplasmic Antibody

This report studies sales (consumption) of Anti-Neutrophil Cytoplasmic Antibody in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Roche Group (Switzerland)
• Beckman Coulter, Inc. (US)
• Abbott Diagnostics (UK)
• Bio-Rad Laboratories, Inc. (US)
• Meridian Life Science, Inc. (US)
• Dako (Denmark)
• Millipore Corporation (US)
• MorphoSys AG (Germany)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti-Neutrophil Cytoplasmic Antibody in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Anti-Neutrophil Cytoplasmic Antibody Market Report 2016

1 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY OVERVIEW

1.1 Product Overview and Scope of Anti-Neutrophil Cytoplasmic Antibody
1.2 Classification of Anti-Neutrophil Cytoplasmic Antibody
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti-Neutrophil Cytoplasmic Antibody
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti-Neutrophil Cytoplasmic Antibody (2011-2021)
  1.4.1 United States Anti-Neutrophil Cytoplasmic Antibody Sales and Growth Rate (2011-2021)
  1.4.2 United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY COMPETITION BY MANUFACTURERS

2.1 United States Anti-Neutrophil Cytoplasmic Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti-Neutrophil Cytoplasmic Antibody Average Price by Manufactures (2015 and 2016)
2.4 Anti-Neutrophil Cytoplasmic Antibody Market Competitive Situation and Trends
  2.4.1 Anti-Neutrophil Cytoplasmic Antibody Market Concentration Rate
  2.4.2 Anti-Neutrophil Cytoplasmic Antibody Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Anti-Neutrophil Cytoplasmic Antibody Sales and Market Share by Type (2011-2016)
3.2 United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Market Share by Type (2011-2016)
3.3 United States Anti-Neutrophil Cytoplasmic Antibody Price by Type (2011-2016)
3.4 United States Anti-Neutrophil Cytoplasmic Antibody Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Anti-Neutrophil Cytoplasmic Antibody Sales and Market Share by Application (2011-2016)
4.2 United States Anti-Neutrophil Cytoplasmic Antibody Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY MANUFACTURERS PROFILES/ANALYSIS

5.1 Roche Group (Switzerland)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Roche Group (Switzerland) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Beckman Coulter, Inc. (US)
  5.2.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Beckman Coulter, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Abbott Diagnostics (UK)
  5.3.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Abbott Diagnostics (UK) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bio-Rad Laboratories, Inc. (US)
  5.4.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bio-Rad Laboratories, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Meridian Life Science, Inc. (US)
  5.5.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Meridian Life Science, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Dako (Denmark)
  5.6.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Dako (Denmark) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Millipore Corporation (US)
  5.7.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Millipore Corporation (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 MorphoSys AG (Germany)
  5.8.2 Anti-Neutrophil Cytoplasmic Antibody Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 MorphoSys AG (Germany) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY MANUFACTURING COST ANALYSIS

6.1 Anti-Neutrophil Cytoplasmic Antibody Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anti-Neutrophil Cytoplasmic Antibody

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Anti-Neutrophil Cytoplasmic Antibody Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anti-Neutrophil Cytoplasmic Antibody Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY MARKET FORECAST (2016-2021)

10.1 United States Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue Forecast (2016-2021)
10.2 United States Anti-Neutrophil Cytoplasmic Antibody Sales Forecast by Type (2016-2021)
10.3 United States Anti-Neutrophil Cytoplasmic Antibody Sales Forecast by Application (2016-2021)
10.4 Anti-Neutrophil Cytoplasmic Antibody Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Neutrophil Cytoplasmic Antibody
Table Classification of Anti-Neutrophil Cytoplasmic Antibody
Figure United States Sales Market Share of Anti-Neutrophil Cytoplasmic Antibody by Type in 2015
Table Application of Anti-Neutrophil Cytoplasmic Antibody
Figure United States Sales Market Share of Anti-Neutrophil Cytoplasmic Antibody by Application in 2015
Figure United States Anti-Neutrophil Cytoplasmic Antibody Sales and Growth Rate (2011-2021)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Growth Rate (2011-2021)
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales of Key Manufacturers (2015 and 2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Neutrophil Cytoplasmic Antibody Sales Share by Manufacturers
Figure 2016 Anti-Neutrophil Cytoplasmic Antibody Sales Share by Manufacturers
Table United States Anti-Neutrophil Cytoplasmic Antibody Revenue by Manufacturers (2015 and 2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti-Neutrophil Cytoplasmic Antibody Revenue Share by Manufacturers
Table 2016 United States Anti-Neutrophil Cytoplasmic Antibody Revenue Share by Manufacturers
Table United States Market Anti-Neutrophil Cytoplasmic Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti-Neutrophil Cytoplasmic Antibody Average Price of Key Manufacturers in 2015
Figure Anti-Neutrophil Cytoplasmic Antibody Market Share of Top 3 Manufacturers
Figure Anti-Neutrophil Cytoplasmic Antibody Market Share of Top 5 Manufacturers
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales by Type (2011-2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales Share by Type (2011-2016)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Sales Market Share by Type in 2015
Table United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Market Share by Type (2011-2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-Neutrophil Cytoplasmic Antibody by Type (2011-2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Price by Type (2011-2016)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Sales Growth Rate by Type (2011-2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales by Application (2011-2016)
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales Market Share by Application (2011-2016)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Sales Market Share by Application in 2015
Table United States Anti-Neutrophil Cytoplasmic Antibody Sales Growth Rate by Application (2011-2016)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Sales Growth Rate by Application (2011-2016)
Table Roche Group (Switzerland) Basic Information List
Table Roche Group (Switzerland) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Group (Switzerland) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Beckman Coulter, Inc. (US) Basic Information List
Table Beckman Coulter, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Abbott Diagnostics (UK) Basic Information List
Table Abbott Diagnostics (UK) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Diagnostics (UK) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Basic Information List
Table Bio-Rad Laboratories, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Meridian Life Science, Inc. (US) Basic Information List
Table Meridian Life Science, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meridian Life Science, Inc. (US) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Dako (Denmark) Basic Information List
Table Dako (Denmark) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dako (Denmark) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Millipore Corporation (US) Basic Information List
Table Millipore Corporation (US) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table Millipore Corporation (US) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table MorphoSys AG (Germany) Basic Information List
Table MorphoSys AG (Germany) Anti-Neutrophil Cytoplasmic Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Table MorphoSys AG (Germany) Anti-Neutrophil Cytoplasmic Antibody Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Neutrophil Cytoplasmic Antibody
Figure Manufacturing Process Analysis of Anti-Neutrophil Cytoplasmic Antibody
Figure Anti-Neutrophil Cytoplasmic Antibody Industrial Chain Analysis
Table Raw Materials Sources of Anti-Neutrophil Cytoplasmic Antibody Major Manufacturers in 2015
Table Major Buyers of Anti-Neutrophil Cytoplasmic Antibody
Table Distributors/Traders List
Figure United States Anti-Neutrophil Cytoplasmic Antibody Production and Growth Rate Forecast (2016-2021)
Figure United States Anti-Neutrophil Cytoplasmic Antibody Revenue and Growth Rate Forecast (2016-2021)
Table United States Anti-Neutrophil Cytoplasmic Antibody Production Forecast by Type (2016-2021)
Table United States Anti-Neutrophil Cytoplasmic Antibody Consumption Forecast by Application (2016-2021)